申请人:Taisho Pharmaceutical Co., Ltd.
公开号:US06291467B1
公开(公告)日:2001-09-18
An aromaheterocyclic derivative represented by the formula:
wherein Z is a group represented by the following formula:
wherein Ar1 is a phenyl group or a phenyl group substituted with a halogen atom or an alkyl group of 1 to 5 carbon atoms, R2 is an alkyl group of 1 to 5 carbon atoms, Y is a hydrogen atom, a mercapto group, an alkylthio group of 1 to 5 carbon atoms, an amino group or an amino group substituted with one or two alkyl groups having 1 to 5 carbon atoms, Ar2 is a phenyl group of one or two substituents selected from the group consisting of a halogen atom, an alkyl group of 1 to 5 carbon atoms, an alkoxy group of 1 to 5 carbon atoms, a hydroxyl group and a trifluoromethyl group, or a phenyl group, B1-B2 is CH—CO or C═C(R1) (wherein R1 is a hydrogen atom or an alkyl group of 1 to 5 carbon atoms), and n is an integer of 1 to 4, or a pharmaceutically acceptable salt thereof, which is a dopamine D4 receptor antagonist compound having an antipsychotic action without causing extrapyramidal diseases.
一种芳香杂环衍生物,其化学式表示为:其中Z是由以下式子表示的基团:其中Ar1是苯基或被卤素原子或1至5个碳原子的烷基取代的苯基,R2是1至5个碳原子的烷基,Y是氢原子、巯基、1至5个碳原子的烷硫基、氨基或被1至2个1至5个碳原子的烷基取代的氨基,Ar2是一个苯基,其中可以有一个或两个取代基,所述取代基选择自卤素原子、1至5个碳原子的烷基、1至5个碳原子的烷氧基、羟基和三氟甲基基团,或者是一个苯基,B1-B2是CH-CO或C═C(R1)(其中R1是氢原子或1至5个碳原子的烷基),n是1至4的整数,或其药学上可接受的盐,是一种多巴胺D4受体拮抗剂化合物,具有抗精神病作用,不会引起锥体外系疾病。